109. Atypical hemolytic uremic syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 114 / Drugs : 36 - (DrugBank : 7) / Drug target genes : 3 - Drug target pathways : 11
Atypical hemolytic uremic syndrome and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
| ID | Diseases (Sorted by drug repositionability) |
|---|---|
| 109 | Atypical hemolytic uremic syndrome |
| 66 | IgA nephropathy |
| 222 | Primary nephrotic syndrome |
| 62 | Paroxysmal nocturnal hemoglobinuria |
| 61 | Autoimmune hemolytic anemia |